Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in medications like Wegovy, works by activating GLP-1 receptors in your brain and pancreas to reduce hunger and improve blood sugar control. During the first month of treatment, patients typically experience weight loss ranging from 2 to 8 pounds, depending on baseline weight, adherence, and metabolic factors. Understanding what to expect can help you stay motivated and recognize whether your response aligns with clinical norms.
Realistic First-Month Weight Loss Results on Semaglutide
Clinical trials show that semaglutide produces measurable weight reduction within days to weeks of starting treatment. The landmark STEP 1 trial demonstrated that participants on semaglutide lost an average of 5 to 8 pounds in the first month, with some variation based on starting dose and body composition. Most people notice appetite suppression before they see scale movement, which typically appears by week 3 or 4 of consistent dosing.
Your individual first-month loss depends on several factors: your starting body weight (heavier individuals often lose more pounds initially), baseline metabolism, adherence to your prescribed dose schedule, and dietary changes you make alongside treatment. Patients who combine semaglutide with reduced calorie intake and increased physical activity tend to see results at the higher end of the range. It's important to remember that rapid initial loss often includes water weight, which typically stabilizes in month two.
How Genetics Influence Your Early Weight Loss Response
Your genetic blueprint significantly shapes how quickly you respond to semaglutide in the first month. Key variants in genes like GLP1R (rs6923761) and GIPR (rs1800437) affect how effectively your body's cells receive and respond to the medication's signals. PlexusDx's Precision Peptide Genetic Test identifies these variants and maps your unique peptide pathways across 49 different compounds, revealing whether you have optimal, intermediate, or variable response predictions for GLP-1 therapy.
Variants in the FTO gene (rs9939609) and MC4R (rs17782313) also influence your baseline appetite regulation and energy expenditure, which directly impacts how semaglutide performs during your first month on treatment. Understanding your genetic predispositions allows PlexusDx to help personalize your therapy approach—potentially adjusting starting dose strategies or selecting alternative compounds like tirzepatide if your genetic profile suggests it may work better for your system. Testing at month one provides data that can optimize your months two through six results.
What Happens During Week One Through Week Four
Week one after your first semaglutide injection typically brings appetite suppression as the primary symptom—many patients report feeling satisfied with smaller portion sizes and experiencing reduced cravings. You may notice subtle changes in food preferences, with sweets or fatty foods becoming less appealing. Most people don't see scale movement during week one, but this suppressed appetite is the mechanism driving weight loss over the coming weeks.
By weeks two and three, consistent appetite reduction combined with lower calorie intake starts translating to visible weight loss. Water weight begins dropping, and some patients experience modest changes in how their clothes fit. Week four is when cumulative weight loss becomes more apparent on the scale, often ranging from 2 to 5 pounds depending on your adherence and dietary intake.
Side effects during this period—including nausea, mild digestive changes, or reduced appetite for favorite foods—are normal and typically improve as your body adjusts. These effects actually support weight loss by naturally reducing your food intake without requiring willpower-dependent restriction. If side effects are significant, talking to your PlexusDx provider about dose adjustment or timing strategies can help optimize your comfort while maintaining therapeutic benefit.
Optimizing Your Results: Diet, Exercise, and Medication Adherence
Semaglutide works best when combined with intentional dietary choices and consistent physical activity. During your first month, focus on protein-rich foods, adequate hydration, and regular movement—even gentle daily walks amplify semaglutide's weight loss effect. Many patients find that semaglutide naturally reduces processed food cravings, making it easier to choose whole foods without active restriction.
Medication adherence is critical during month one: taking your injection on schedule and at the prescribed dose ensures your body establishes consistent GLP-1 receptor stimulation. Missing doses or irregular timing delays your body's adaptation and can reduce first-month results. Keep a simple dosing calendar and set phone reminders to maintain consistency. If you're on an escalating dose protocol (like starting at 0.25 mg and increasing weekly), following the exact schedule your provider recommends ensures you reach an effective dose by month's end.
PlexusDx compounded semaglutide injections start at just $149 per month, making consistent, high-quality treatment accessible without insurance. This affordability removes cost barriers that might otherwise interrupt your therapy during the critical first month when you're establishing your weight loss momentum and letting your body adjust to the medication.
When to Adjust Your Expectations or Dose
If you complete your first month and see minimal to no weight loss despite good adherence and dietary effort, several explanations are possible. Your starting dose may be subtherapeutic for your body weight or genetics, your GLP-1 receptor sensitivity may require a different medication (like tirzepatide, which targets two pathways), or other metabolic factors may need addressing. This is not treatment failure—it's simply data showing you need personalization.
Your PlexusDx provider can review your first-month response and recommend a dose increase (remember: your dose may need to go up, but your price won't stay at $149 per month for compounded semaglutide), a compound switch, or consideration of the Precision Peptide Genetic Test ($99 as an add-on) to identify which peptide pathways your genetics favor most. Many patients who don't see results until dose escalation experience accelerated weight loss once their dose reaches their individual sweet spot, often between weeks 5 and 8 as their body fully adjusts.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is 5 pounds in the first month a good result with semaglutide?
Yes—5 pounds represents solid progress aligned with clinical trial data. Many patients see 2 to 8 pounds depending on starting weight and adherence, so 5 pounds puts you in the middle-to-upper range of expectations. Weight loss typically accelerates in months two through three as your body continues adjusting.
Why am I not losing weight in week one of semaglutide?
Week one typically produces appetite suppression before visible weight loss. Your body needs 2 to 4 weeks of consistent reduced calorie intake to generate measurable weight loss, and some initial loss will be water rather than fat. If appetite suppression isn't occurring, contact your provider about dose timing or adjustment.
Can I start semaglutide at a higher dose to lose more weight in month one?
Higher starting doses increase side effect risk without proportionally accelerating month-one weight loss. Standard dose escalation protocols (like 0.25 mg weekly increases) allow your body to adapt while building to therapeutic doses by week 3 or 4. PlexusDx providers follow evidence-based protocols to balance safety and efficacy.
What's the cost of semaglutide at PlexusDx, and does price change with dose increases?
PlexusDx compounded semaglutide injections start at $149 per month—a flat rate that doesn't increase as your therapeutic dose climbs. This means you can optimize your dose based on your response without worrying about higher monthly costs. HSA and FSA plans also cover PlexusDx medications.
How does the Precision Peptide Genetic Test help predict my first-month results?
The Precision Peptide Genetic Test ($99 add-on in month two) analyzes key variants like GLP1R rs6923761 and GIPR rs1800437 that directly influence how your body responds to semaglutide. If your genetics suggest weaker GLP-1 pathway response, your provider might recommend tirzepatide (which activates two pathways) or dose optimization strategies earlier, potentially improving your overall weight loss trajectory.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Am I Losing So Much Weight on Ozempic?
What to Expect After Your First Ozempic Shot: A Guide